Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. (Q48187686)

9 February 2018

title

Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. (English)

1 reference

9 February 2018

1 reference

Philipp A Csomor

1

1 reference

9 February 2018

Renée R Stadler

2

1 reference

9 February 2018

Joram Feldon

3

1 reference

9 February 2018

Benjamin K Yee

4

1 reference

9 February 2018

Mark A Geyer

5

1 reference

9 February 2018

Franz X Vollenweider

6

1 reference

9 February 2018

language of work or name

English

0 references

publication date

25 April 2007

1 reference

9 February 2018

published in

Neuropsychopharmacology

1 reference

9 February 2018

volume

33

1 reference

9 February 2018

issue

3

1 reference

9 February 2018

page(s)

497-512

1 reference

9 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301421

exact match

0 references

cites work

Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Sensory physiology and catecholamines in schizophrenia and mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Yohimbine impairs P50 auditory sensory gating in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Neurophysiological studies of sensory gating in rats: effects of amphetamine, phencyclidine, and haloperidol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Olanzapine effects on auditory sensory gating in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Neurophysiological assessment of sensory gating in psychiatric inpatients: comparison between schizophrenia and other diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of amisulpride, risperidone and chlorpromazine on auditory and visual latent inhibition, prepulse inhibition, executive function and eye movements in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Clozapine, but not typical antipsychotics, correct P50 suppression deficit in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Increased prepulse inhibition of the acoustic startle response is associated with better strategy formation and execution times in healthy males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Prestimulus effects on human startle reflex in normals and schizophrenics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Cognitive Deficit Caused by Regional Depletion of Dopamine in Prefrontal Cortex of Rhesus Monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Impaired startle prepulse inhibition and habituation in patients with schizotypal personality disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Modulation of the startle response and startle laterality in relatives of schizophrenic patients and in subjects with schizotypal personality disorder: evidence of inhibitory deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Poor P50 suppression among schizophrenia patients and their first-degree biological relatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Differential effects of ketamine on gating of auditory evoked potentials and prepulse inhibition in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

A model of prefrontal cortex dopaminergic modulation during the delayed alternation task

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Sensory gating in rats: lack of correlation between auditory evoked potential gating and prepulse inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

The prefrontal landscape: implications of functional architecture for understanding human mentation and the central executive

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Presidential Address, 1974. The more or less startling effects of weak prestimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of quetiapine and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Startle gating deficits occur across prepulse intensities in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Sensorimotor gating deficits and hypofrontality in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Executive function in first-episode schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of bromocriptine on human subjects depend on working memory capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Reduced prepulse inhibition in unaffected siblings of schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Neural correlates of tactile prepulse inhibition: a functional MRI study in normal and schizophrenic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Prepulse inhibition of the startle response in risperidone-treated patients: comparison with typical antipsychotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of typical and atypical antipsychotics on prepulse inhibition and latent inhibition in chronic schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Distribution of dopaminergic receptors in the primate cerebral cortex: quantitative autoradiographic analysis using [3H]raclopride, [3H]spiperone and [3H]SCH23390.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of MDMA (ecstasy) on prepulse inhibition and habituation of startle in humans after pretreatment with citalopram, haloperidol, or ketanserin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Human and animal studies of schizophrenia-related gating deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Measuring P50 suppression and prepulse inhibition in a single recording session.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Amphetamine disrupts P50 suppression in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Sulpiride and mnemonic function: effects of a dopamine D2 receptor antagonist on working memory, emotional memory and long-term memory in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Systemic sulpiride modulates striatal blood flow: relationships to spatial working memory and planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Improved short-term spatial memory but impaired reversal learning following the dopamine D(2) agonist bromocriptine in human volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis--a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Sensory gating in schizophrenics and normal controls: effects of changing stimulation interval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Prepulse inhibition and P50 suppression: commonalities and dissociations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Modulating sensory gating in healthy volunteers: the effects of ketamine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Increasing dopaminergic activity: effects of L-dopa and bromocriptine on human sensory gating

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

P50 suppression and prepulse inhibition of the startle reflex in humans: a correlational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Planning and spatial working memory following frontal lobe lesions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Double dissociations of memory and executive functions in working memory tasks following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Whispered voice test for screening for hearing impairment in adults and children: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Sensorimotor gating and habituation of the startle response in schizophrenic patients randomly treated with amisulpride or olanzapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Chemistry of the mind: neurochemical modulation of prefrontal cortical function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Concurrent assessment of acoustic startle and auditory P50 evoked potential measures of sensory inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Specific impairments of planning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Disruption of sensory gating by the alpha 2 selective noradrenergic antagonist yohimbine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Inverted-U profile of dopamine-NMDA-mediated spontaneous avalanche recurrence in superficial layers of rat prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Changes in sensorimotor inhibition across the menstrual cycle: implications for neuropsychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Cognitive impairments in patients with schizophrenia displaying preserved and compromised intellect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Modulation of memory fields by dopamine D1 receptors in prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Dopamine antagonists in the orbital prefrontal cortex reduce prepulse inhibition of the acoustic startle reflex in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Spatial working memory and planning ability: contrasts between schizophrenia and bipolar I disorder.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

P50 and acoustic startle gating are not related in healthy participants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Prepulse inhibition of the acoustic startle response of rats is reduced by 6-hydroxydopamine lesions of the medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Autoradiographic localization of D1 and D2 dopamine receptors in the human brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Effect of treatment status on prepulse inhibition of acoustic startle in schizophrenia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

A cellular mechanism for prepulse inhibition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Effects of ketanserin and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Effects of haloperidol and clozapine on prepulse inhibition of the acoustic startle response and the N1/P2 auditory evoked potential in man.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Prepulse Inhibition of the Startle Response in Men With Schizophrenia: Effects of Age of Onset of Illness, Symptoms, and Medication

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

The differential effects of chlorpromazine and haloperidol on latent inhibition in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Gating of auditory P50 in schizophrenics: unique effects of clozapine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301421

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1301421

1 reference

9 February 2018

PubMed ID

17460616

1 reference

9 February 2018